LMAN2 抗体 (C-Term)
Quick Overview for LMAN2 抗体 (C-Term) (ABIN2302417)
抗原
See all LMAN2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 284-314, C-Term
- 
                                            交叉反应
- 人
- 
                                            交叉反应 (详细)
- Calculated cross reactivity: Hu
- 
                                            产品特性
- LMAN2, CT (LMAN2, C5orf8, Vesicular integral-membrane protein VIP36, Glycoprotein GP36b, Lectin mannose-binding 2, Vesicular integral-membrane protein 36)
- 
                                            纯化方法
- Purified by Protein A affinity chromatography.
- 
                                            免疫原
- LMAN2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 284-314 amino acids from the C-terminal region of human LMAN2.
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working conditions should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- -20°C
 
- 
                                            
- 
    - LMAN2 (Lectin, Mannose-Binding 2 (LMAN2))
- 
                                            别名
- LMAN2
- 
                                            NCBI登录号
- NP_006807
- 
                                            UniProt
- Q12907
- 
                                            途径
- SARS-CoV-2 Protein Interactome
 抗原
- 
                    
 
                                     
                                     
                                    